To Screen or Not to Screen? Office of Inspector General ("OIG") Updates Special Advisory Bulletin on Exclusion from Participation in Federal Health Care Programs

Update: Regulation for COVID-19 clinical trials conducted with medicinal products containing or consisting of GMOs has now been adopted